Xeris Biopharma Holdings Inc. buy SVB Leerink LLC
Start price
22.08.25
/
50%
€6.61
Target price
22.08.26
€7.75
Performance (%)
-30.71%
Price
25.03.26
€4.58
Summary
This prediction is currently active. Massive losses of -30.71% have been the result for the BUY prediction by SVB_Leerink_LLC. This prediction currently runs until 22.08.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | -5.723% | -5.723% |
| iShares Core DAX® | -1,03 % | -9,17 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % |
| iShares S&P 500 | -1,20 % | -2,99 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) had its price target raised by analysts at Leerink Partners from $7.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by SVB_Leerink_LLC for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€4.21
10.03.25
10.03.25
€5.52
10.03.26
10.03.26
17.02%
11.03.26
11.03.26
